Formulation and evaluation of mefenamic acid sustained release matrix pellets

1. H. Bechgaard and G. H. Nielsen, Controlled-release multiple-units and single-unit doses. A literature review, Drug Dev. Ind. Pharm. 4 (1978) 53-67; DOI: 10.3109/03639047809055639.10.3109/03639047809055639Search in Google Scholar

2. K. A. Mehta, M. S. Kislalioglu, W. Phuapradit, A. W. Malick and N. H. Shah, Release performance of a poorly soluble drug from a novel, Eudragit®-based multi-unit erosion matrix, Int. J. Pharm. 213 (2001) 7-12; DOI: 10.1016/S0378-5173 (00)00594-9.Search in Google Scholar

3. P. W. Heng, 15th International Symposium on Microencapsulation, Parma (Italy), September 18-21, 2005.Search in Google Scholar

4. T. Schaefer, P. Holm and H. G. Kristensen, Melt granulation in a laboratory scale high shear mixer, Drug Dev. Ind. Pharm. 19 (1990) 1249-1277; DOI: 10.3109/03639049009115960.10.3109/03639049009115960Search in Google Scholar

5. O. L. Sprockel, M. Sen, P. Shivanand and W. Prapaitrakul, A melt extrusion process for manufacturing matrix drug delivery systems, Int. J. Pharm. 155 (1997) 191-199; DOI: 10.1016/S0378- -5173(97)00165-8.Search in Google Scholar

6. C. De Brabander, C. Vervaet and J. P. Remon, Development and evaluation of sustained release mini-matrices prepared via hot melt extrusion, J. Control. Release 89 (2003) 235-247; DOI: 10.1016/ S0168-3659(03)00075-0.10.1016/S0168-3659(03)00075-0Search in Google Scholar

7. N. Follonier, E. Doelker and E. T. Cole, Evaluation of hot melt extrusion as a new technique for the development of polymer base pellets for sustained release capsules containing high loadings of freely soluble drugs, Drug Dev. Ind. Pharm. 20 (1994) 1323-1339; DOI: 10.3109/03639049409038373.10.3109/03639049409038373Search in Google Scholar

8. F. Siepmann, S. Muschert, M. P. Flament, P. Leterme, A. Gayot and J. Siepmann, Controlled drug release from Gelucire based matrix pellets: Experiment and theory, Int. J. Pharm. 317 (2006) 136-143; DOI: 10.1016/j.ijpharm.2006.03.006.10.1016/j.ijpharm.2006.03.006Search in Google Scholar

9. E. S. Ghali, G. H. Klinger and J. B. Schwartz, Thermal treatment of beads with wax for controlled release, Drug Dev. Ind. Pharm. 15 (1989) 1311-328; DOI: 10.3109/03639048909062747.10.3109/03639048909062747Search in Google Scholar

10. R. Chatlapalli and B. D. Rohera, Study of effect of excipient source variation on rheological behavior of diltiazem HCl-HPMC wet masses using a mixer torque rheometer, Int. J. Pharm. 238 (2002) 139-151; DOI: 10.1016/S0378-5173(02)00065-0.10.1016/S0378-5173(02)00065-0Search in Google Scholar

11. J. L. P. Soh, C. W. Liew and P. W. S. Heng, Torque rheological parameters to predict pellet quality in extrusion-spheronization, Int. J. Pharm. 315 (2006) 99-109; DOI: 10.1016/j.ijpharm.2006.02.023.10.1016/j.ijpharm.2006.02.023Search in Google Scholar

12. G. M. Mahrous, M. A. Ibarhim, M. El-Badry and F. K. Al-Anazi, Indomethacin sustained release pellets prepared by extrusion/spheronization, J. Drug Deliv. Sci. Technol. 20 (2010) 119-125.10.1016/S1773-2247(10)50016-9Search in Google Scholar

13. L. Fang, S. Numajiri, D. Kobayashi, H. Ueda, K. Nakayama, H. Miyamae and Y. Morimoto, Physicochemical and crystallographic characterization of mefenamic acid complexes with alkanolamines, J. Pharm. Sci. 93 (2004) 144-154; DOI: 10.1002/jps.10468.10.1002/jps.1046814648644Search in Google Scholar

14. D. Shinkuma, T. Hamaguchi, Y. Yamanaka and N. Mizuno, Correlation between dissolution rate and bioavailability of different commercial mefenamic acid capsules, Int. J. Pharm. 21 (1984) 187-200; DOI: org/10.1016/0378-5173(84)90093-0.10.1016/0378-5173(84)90093-0Search in Google Scholar

15. C. V.Winder, D. H. Kaump, A. J. Glazko and E. L.Holmes, Pharmacology of the Fenamates - ExperimentalObservations on Flufenamic, Mefenamic, and Meclofenamic Acids, in Supplement to Annals ofPhysical Medicine - Fenamates in Medicine, Symposium (Ed. P. H. Kendall), Bailliere, Tindall and Cassell, London 1966.10.1093/rheumatology/VIII.suppl_1.7Search in Google Scholar

16. J. E. F. Reynolds, Martindale: The Extra Pharmacopoeia, 31rd ed., The Pharmaceutical Press, London 1998, pp. 58-59.Search in Google Scholar

17. A. Avgerinos and S. Malamataris, Bioavailability of controlled release indomethacin microspheres and pellets, Int. J. Pharm. 63 (1990) 77-80; DOI: org/10.1016/0378-5173(90)90104-C.10.1016/0378-5173(90)90104-CSearch in Google Scholar

18. J. S. Rowe and J. E. Carless, Comparison of the in vitro dissolution behaviour of various indomethacin formulations with their in vivo bioavailability, J. Pham. Pharma. 33 (1981) 561-464; DOI: 10.1111/j.2042-7158.1981.tb13866.x.10.1111/j.2042-7158.1981.tb13866.xSearch in Google Scholar

19. S. Y. Khan and M. Akhter, Glyceride derivatives as potential prodrugs: synthesis, biological activity and kinetic studies of glyceride derivatives of mefenamic acid, Pharmazie 60 (2005) 110-114.Search in Google Scholar

20. F. Sevgi, B. Kaynarsoy, M. Ozyazici, Ç. Pekcetin and D. Özyurt, A comparative histological study of alginate beads as a promising controlled release delivery for mefenamic acid, Pharm. Dev. Technol. 13 (2008) 387-392; DOI: 10.1080/10837450802244876.10.1080/10837450802244876Search in Google Scholar

21. P. C. Chen, Y. J. Park, L. C. Chang, D. S. Kohane, R. R. Bartlett, R. Langer and V. C. Yang, Injectable microparticle-gel system for prolonged and localized lidocaine release. I. In vitro characterization, J. Biomed. Mater. Res. A. 70 (2004) 412-419; DOI: 10.1002/jbm.a.30086.10.1002/jbm.a.30086Search in Google Scholar

22. M. D. Parker, R. C. Rowe and N. G. Upjohn, Mixer torque rheometry: A method for quantifying the consistency of wet granulations, Pharm. Tech. Int. 2 (1990) 50-64.Search in Google Scholar

23. M. D. Parker, P. York and R. C. Rowe, Binder-substrate interactions in wet granulation. 1: The effect of binder characteristics, Int. J. Pharm. 64 (1990) 207-216.Search in Google Scholar

24. P. Luukkonen, T. Schæfer, L. Hellén, A. M. Juppo and J. Yliruusi, Rheological characterization of microcrystalline cellulose and silicified microcrystalline cellulose wet masses using a mixer torque rheometer, Int. J. Pharm. 188 (1999) 181-192; DOI: 10.1016/S0928-0987(00)00197-4.10.1016/S0928-0987(00)00197-4Search in Google Scholar

25. V. R. Sinha, A. Aggarwal, S. Srivastava and H. Goel, Influence of operational variables in multi- -particulate delayed release systems for colon-targeted drug delivery of celecoxib using extrusion spheronization, Asian J. Pharm. 4 (2010) 102-109; DOI: 10.4103/0973-8398.68460.10.4103/0973-8398.68460Search in Google Scholar

26. M. F. L. Law and P. B. Deasy, Use of canonical and other analyses for the optimization of an extrusion-spheronization process for indomethacin, Int. J. Pharm. 146 (1997) 1-9; DOI: 10.1016/ S0378-5173(96)04741-2.10.1016/S0378-5173(96)04741-2Search in Google Scholar

27. M. A. Ibrahim, G. M. Mahrous, M. El-Badry and F. K. Al-Anazi, Indomethacin-loaded pellets prepared by extrusion/spheronization: Effect of cosolvents, Farmacia 59 (2011) 483-499.Search in Google Scholar

28. F. Zhou, C. Vervaet and J. P. Remon, Matrix pellets based on the combination of waxes, starches and maltodextrins, Int. J. Pharm. 133 (1996) 155-160; DOI: 10.1016/0378-5173(95)04431-0.10.1016/0378-5173(95)04431-0Search in Google Scholar

29. C. M. Adeyeye and J. C. Price, Development and evaluation of sustained-release ibuprofen-wax microspheres. II. In vitro dissolution studies, Pharm. Res. 11 (1994) 575-579; DOI: 10.1023/A: 1018931002991.Search in Google Scholar

30. R. W. Korsmeyer and N. A. Peppas, Macromolecular and Modeling Aspects of Swelling-controlledSystems, in Controlled Release Delivery Systems (Eds. T. J. Roseman and S. Z. Mansdorf), Dekker, New York 1983, pp. 77 -101.Search in Google Scholar

31. R.W. Korsmeyer, R. Gurny, E. Docler, P. Buri and N. A. Peppas, Mechanism of solute release from porous hydrophilic polymers, Int. J. Pharm. 15 (1983) 25-35; DOI: 10.1016/0378-5173(83)90064-9.10.1016/0378-5173(83)90064-9Search in Google Scholar

32. P. L. Ritger and N. A. Peppas, A simple equation for description of solute release ii. Fickian and anomalous release from swellable devices, J. Control. Release, 5 (1987) 37-42; DOI: 10.1016/0168- -3659(87)90035-6.Search in Google Scholar